跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,485 条关于
“Nanjing University”
全部
18,485
临床试验
4,050
药物
2,861
机构
2,719
资讯
8,855
去年
China's BNCT Cancer Treatment Breakthrough: Neuboron Medical Group Reports Success with First Domestic System
去年
XJTLU Scientists Develop Ultra-Stable Nanoparticles with 40% Drug Loading Capacity for Enhanced Cancer Treatment
去年
Chinese Scientists Develop Promising Nanovaccine to Prevent Arterial Plaque Build-up
9个月前
Tislelizumab Plus Chemoradiotherapy Shows Superior Response Rates in Gastric Cancer Trial
去年
Levothyroxine Trial to Evaluate Cardiovascular Benefits in Elderly with Subclinical Hypothyroidism
去年
Keytruda Demonstrates Overall Survival Benefit in Advanced Hepatocellular Carcinoma
去年
Simcere's Sanbexin Receives FDA Breakthrough Therapy Designation for Acute Ischemic Stroke
去年
Nanjing Leads Biolabs Soars 122% on Hong Kong Debut Following HK$1.1 Billion IPO
8个月前
Nanjing Delova's QP-6211 Achieves Primary Endpoints in Phase 3 Trials for Postoperative Pain Management
去年
Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease
第 1 页,共 886 页
上一页
下一页